mdh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder – A systematic review and a meta-analysis
Karolinska Institutet, Stockholm, Sweden .
Karolinska Institutet, Stockholm, Sweden .
Karolinska Institutet, Stockholm, Sweden .
Mälardalen University, School of Health, Care and Social Welfare, Health and Welfare.ORCID iD: 0000-0002-4537-030X
Show others and affiliations
2016 (English)In: Journal of Affective Disorders, ISSN 0165-0327, E-ISSN 1573-2517, Vol. 205, p. 1-12Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

Background There has been a steady increase in the prescription of antidepressants for the elderly. This study comprises a systematic review of randomized, placebo-controlled trials of antidepressants for treatment of depressive disorder in people aged 65 years or more. Methods PubMed, EMBASE, Cochrane Library, CINAL, and PsycINFO were searched until May 2016. Where appropriate, the results were synthesized in meta-analyses. Results Twelve trials met the inclusion criteria. For patients with major depressive disorder, selective serotonin re-uptake inhibitors (SSRI) were not superior to placebo in achieving remission (OR: 0.79, 95% CI: 0.61–1.03) or response (OR=0.86, 95% CI: 0.51–1.10) after 8 weeks of treatment (three trials). However, maintenance treatment with SSRIs was superior to placebo in preventing relapse (OR: 0.22, 95% CI: 0.13–0.36; NNT=5, 95% CI: 3–6; two trials). Duloxetine was superior to placebo in achieving remission (OR: 1.78, 95% CI: 1.20–2.65; NNT=9, 95% CI: 6–20; three trials) and response (OR: 1.83, 95% CI: 1.96–4.08; two trials) in recurrent major depression after 8 weeks, but increased the risk of adverse events that can be problematic in the elderly. Limitations The quality of evidence was generally low or moderate, emphasizing the uncertainty of the results. Study populations only partly covered the heterogeneous population of elderly with depressed mood, limiting the generalizability. Conclusion The results underscore the importance of close monitoring of the effects of antidepressants in treatment of elderly patients with a depressive disorder. Methods for early detection of non-responders and effective treatment options for this group are needed. 

Place, publisher, year, edition, pages
2016. Vol. 205, p. 1-12
Keyword [en]
Antidepressants, Elderly, MDD, Meta-analysis, Systematic review
National Category
Health Sciences
Identifiers
URN: urn:nbn:se:mdh:diva-32509DOI: 10.1016/j.jad.2016.06.013ISI: 000385440900001Scopus ID: 2-s2.0-84979018733OAI: oai:DiVA.org:mdh-32509DiVA, id: diva2:953795
Available from: 2016-08-18 Created: 2016-08-18 Last updated: 2017-11-28Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records BETA

Söderlund, Anne

Search in DiVA

By author/editor
Söderlund, Anne
By organisation
Health and Welfare
In the same journal
Journal of Affective Disorders
Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 7 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf